VYNE News and Press, VYNE Therapeutics Inc Com From 03/01/21

Announces promising preclinical data on FMX114 Phase 2a clinical study in AD expected to begin in 3Q 2021 with top-line results by year end Further details on FMX114, including clinical development plans, will be discussed on VYNE’s year end 2020 earnings call at 8:30am ET ...

BRIDGEWATER, N.J., Feb. 23, 2021 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that it will report its financial results for the year ended December 31, 2020, on Thursday, March 4, 2021, before the market open...

VYNE Therapeutics (VYNE) down 5% premarket as the company's stock-split of common shares becomes effective today.On Feb. 11, the Company's Board of Directors approved a reverse stock split at a ratio of 1-for-4.Once effective, the reverse stock split will reduce the number of common...

BRIDGEWATER, N.J., Feb. 11, 2021 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that its Board of Directors has approved a reverse stock split of the Company’s common stock at a ratio of 1-for-4...

VYNE Therapeutics (VYNE) has gained ~38.9% since the company announced last week that the FDA has authorized the inclusion of new information in the product label for AMZEEQ® (minocycline) topical foam, 4%.The label update refers to a low propensity of P. acnes strains to devel...

These Penny Stocks Are Climbing Faster Than The S&P This Week When it comes to finding the best penny stocks , traders will often go with the most popular choices. Searching for hot topics on Reddit and other social media outlets has become somewhat normal in 2021. But you can&#...

Artelo Biosciences (ARTL) +78%.Moleculin Biotech (MBRX) +49% on announcing 100% survival achieved in Osteosarcoma Lung Metastases Animal Model.DURECT (DRRX) +42% after FDA approval for Posimir.Holicity (HOLUU) +38% on plan to take rocket maker Astra public.Tiziana Life Sciences...

Gainers: [[PRTA]] +35.6%. [[CRBP]] +30.0%. [[GPRO]] +6.8%. [[VYNE]] +5.7%. [[LOTZ]] +3.6%.Losers: [[CRUS]] -7.5%. [[RMBS]] -6.3%. [[STRO]] -6.0%. [[ALTR]] -5.4%. [[NERV]] -5.1%. For further details see: PRTA, RMBS, NERV and GPRO among after-hours movers

Are Robinhod Penny Stocks Still A Buy? Robinhood continues to captivate headlines & penny stocks are right up there with it. The mobile-first trading app has been the center of attention and scrutiny following last week’s events. With massive short squeezes from the likes...

BRIDGEWATER, N.J., Feb. 01, 2021 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a specialty pharmaceutical company focused on developing and commercializing proprietary therapies to address unmet needs in dermatology, today a...